恶意 发表于 2025-3-27 00:10:53

http://reply.papertrans.cn/1/47/4676/4676-31.png

CHURL 发表于 2025-3-27 04:14:27

Submitted on: 05 September 2016.
Revised on: 12 December 2016.
Accepted on: 06 February 2017.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

不能强迫我 发表于 2025-3-27 08:37:54

http://reply.papertrans.cn/1/47/4676/4676-33.png

negotiable 发表于 2025-3-27 11:01:49

Submitted on: 13 September 2023.
Revised on: 06 January 2024.
Accepted on: 24 January 2024.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

Fibrillation 发表于 2025-3-27 16:58:14

http://reply.papertrans.cn/1/47/4676/4676-35.png

Bmd955 发表于 2025-3-27 20:27:12

http://reply.papertrans.cn/1/47/4676/4676-36.png
页: 1 2 3 [4]
查看完整版本: SCIE期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY 2024/2025影响因子:2.771 (CANCER CHEMOTH PHARM) (0344-5704). (ONCOLOGY)(肿瘤学)Scien